Company intelligence / Profile preview
Roemmers
- Ownership
- Private
- Development stage
- Other
Overview
Roemmers is the leading pharmaceutical company in Argentina and one of the largest in Latin America, focused on manufacturing and distributing high-quality generic and branded medicines primarily in primary care, with strong market positions in cardiovascular, infectious, metabolic, and neurological diseases. Its top-selling drugs include losartan (for hypertension), amoxicillin (for infections), and compounds targeting metabolic and psychiatric disorders. The company prioritizes local manufacturing and broad market coverage, with regional and international expansion since the 1970s.
- Therapeutic areas
- EndocrinologyRheumatologyPsychiatryInfectious DiseasesGastroenterologyPulmonologyCardiovascularNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Roemmers.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Roemmers.